Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Transpl Infect Dis ; 23(4): e13621, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33877729

ABSTRACT

Hemophagocytic lymphohistiocytosis (HLH) causes multiorgan failure due to the release of multiple cytokines mediating widespread inflammation. We present a patient with multiple myeloma on maintenance chemotherapy with the anti-CD38 monoclonal antibody daratumumab after autologous stem cell transplant (ASCT) who developed fatal HLH secondary to Ehrlichiosis.


Subject(s)
Ehrlichia chaffeensis , Ehrlichiosis , Lymphohistiocytosis, Hemophagocytic , Ehrlichiosis/drug therapy , Humans , Lymphohistiocytosis, Hemophagocytic/etiology , Lymphohistiocytosis, Hemophagocytic/therapy , Multiple Organ Failure/etiology , Stem Cell Transplantation/adverse effects
2.
Transpl Infect Dis ; 21(2): e13052, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30689291

ABSTRACT

BACKGROUND: Autologous stem cell transplantation (ASCT) is a commonly used treatment for multiple myeloma (MM). This retrospective cohort study characterizes the risk factors and outcomes associated with bacteremia following ASCT at a single center. METHODS: We conducted a retrospective analysis in subjects who underwent ASCT for multiple myeloma and other malignancies from May 2014 to March 2015 at a single center. The control cohort included all subjects undergoing ASCT in the same time period who did not develop bacteremia. RESULTS: During the study period, 363 ASCTs were completed in 282 discrete patients. Bacteremia was documented in 13% of all transplants. Enterococcus faecium was the most frequent species overall (14/62, 23%). Vancomycin resistance was present in 93% of E faecium isolates. Bacteremia was associated with a significantly decreased survival in patients who received their transplant after the first year of myeloma treatment. Overall survival (OS) was not significantly different in the two cohorts among patients undergoing ASCT within the first year of myeloma treatment. Survival analysis showed a significantly decreased OS in patients who developed Enterococcus bacteremia as compared to the non-bacteremia cohort. Enterococcal bacteremia was associated with significantly longer duration of neutropenia (mean 14 vs 9.7 days, P = 0.01), hospitalization (mean 61.7 vs 20.4 days, P = 0.0006), and higher mortality (69% vs 25%, P = 0.01) as compared to other bacteremias. CONCLUSION: We found a high incidence of E faecium and a low incidence of MRSA and Pseudomonas bacteremias following ASCT in our patient population. Survival analysis in our cohort suggests that the effect of underlying disease status and cumulative chemotherapy is critically important in determining outcomes related to bacteremia. Enterococcal bacteremias following ASCT were associated with significantly higher morbidity and mortality than non-enterococcal bacteremias.


Subject(s)
Bacteremia/etiology , Multiple Myeloma/therapy , Stem Cell Transplantation/adverse effects , Adult , Aged , Aged, 80 and over , Bacteremia/epidemiology , Disease-Free Survival , Female , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/mortality , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Multiple Myeloma/complications , Pseudomonas Infections/epidemiology , Pseudomonas Infections/mortality , Retrospective Studies , Risk Factors , Staphylococcal Infections/epidemiology , Staphylococcal Infections/mortality , Survival Analysis , Transplantation, Autologous/adverse effects
3.
Microb Ecol ; 76(3): 801-813, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29445826

ABSTRACT

Infections due to Clostridioides difficile (previously known as Clostridium difficile) are a major problem in hospitals, where cases can be caused by community-acquired strains as well as by nosocomial spread. Whole genome sequences from clinical samples contain a lot of information but that needs to be analyzed and compared in such a way that the outcome is useful for clinicians or epidemiologists. Here, we compare 663 public available complete genome sequences of C. difficile using average amino acid identity (AAI) scores. This analysis revealed that most of these genomes (640, 96.5%) clearly belong to the same species, while the remaining 23 genomes produce four distinct clusters within the Clostridioides genus. The main C. difficile cluster can be further divided into sub-clusters, depending on the chosen cutoff. We demonstrate that MLST, either based on partial or full gene-length, results in biased estimates of genetic differences and does not capture the true degree of similarity or differences of complete genomes. Presence of genes coding for C. difficile toxins A and B (ToxA/B), as well as the binary C. difficile toxin (CDT), was deduced from their unique PfamA domain architectures. Out of the 663 C. difficile genomes, 535 (80.7%) contained at least one copy of ToxA or ToxB, while these genes were missing from 128 genomes. Although some clusters were enriched for toxin presence, these genes are variably present in a given genetic background. The CDT genes were found in 191 genomes, which were restricted to a few clusters only, and only one cluster lacked the toxin A/B genes consistently. A total of 310 genomes contained ToxA/B without CDT (47%). Further, published metagenomic data from stools were used to assess the presence of C. difficile sequences in blinded cases of C. difficile infection (CDI) and controls, to test if metagenomic analysis is sensitive enough to detect the pathogen, and to establish strain relationships between cases from the same hospital. We conclude that metagenomics can contribute to the identification of CDI and can assist in characterization of the most probable causative strain in CDI patients.


Subject(s)
Clostridioides difficile/genetics , Clostridioides difficile/isolation & purification , Genome, Bacterial , Amino Acid Sequence , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Bacterial Toxins/metabolism , Clostridioides difficile/chemistry , Clostridioides difficile/classification , Clostridium Infections/microbiology , Gene Dosage , Humans , Molecular Sequence Data , Multilocus Sequence Typing , Phylogeny , Sequence Homology, Amino Acid
4.
Transpl Infect Dis ; 19(5)2017 Oct.
Article in English | MEDLINE | ID: mdl-28708253

ABSTRACT

We present the case of a young man with acute lymphoblastic leukemia who developed cytomegalovirus (CMV) appendicitis after receiving alemtuzumab for acute refractory graft-versus-host disease after allogeneic hematopoietic stem cell transplantation (HSCT). CMV appendicitis is a rare complication; and we are reporting the first case to our knowledge of CMV appendicitis following HSCT. Our case highlights the importance of recognition of CMV viral reactivation following the use of alemtuzumab. Using a preemptive strategy of checking CMV PCR, with initiation of early effective treatment on detection of CMV replication, may be appropriate following use of alemtuzumab in hematologic malignancies in patients after HSCT.


Subject(s)
Appendicitis/virology , Cytomegalovirus Infections/complications , Hematopoietic Stem Cell Transplantation/adverse effects , Adult , Antineoplastic Agents/pharmacology , Antiviral Agents/therapeutic use , Appendicitis/surgery , Cytomegalovirus Infections/drug therapy , Ganciclovir/therapeutic use , Humans , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy
5.
J Clin Virol ; 92: 53-55, 2017 07.
Article in English | MEDLINE | ID: mdl-28531552

ABSTRACT

BACKGROUND: Respiratory viral infections are a significant problem in patients with hematologic malignancies. We report a cluster of HPIV 3 infections in our myeloma patients, and describe the utility of next generation sequencing (NGS) to identify transmission linkages which can assist in infection prevention. OBJECTIVES: To evaluate the utility of NGS to track respiratory viral infection outbreaks and delineate between community acquired and nosocomial infections in our cancer units. STUDY DESIGN: Retrospective chart review conducted at a single site. All patients diagnosed with multiple myeloma who developed symptoms suggestive of upper respiratory tract infection (URTI) or lower respiratory tract infection (LRTI) along with a respiratory viral panel (RVP) test positive for HPIV 3 between April 1, 2016, to June 30, 2016, were included. Sequencing was performed on the Illumina MiSeq™. To gain understanding regarding community strains of HPIV 3 during the same season, we also performed NGS on HPIV3 strains isolated from pediatric cases. RESULTS: We saw a cluster of 13 cases of HPIV3 infections in the myeloma unit. Using standard epidemiologic criteria, 3 cases were considered community acquired, 7 cases developed infection during treatment in the cancer infusion center, while an additional 3 developed infections during hospital stay. Seven patients required hospitalization for a median duration of 20days. NGS enabled sensitive discrimination of the relatedness of the isolates obtained during the outbreak and provided evidence for source of transmission. Two hospital onset infections could be tracked to an index case; the genome sequences of HPIV 3 strains from these 3 patients only differed by a single nucleotide. CONCLUSIONS: NGS offers a significantly higher discriminatory value as an epidemiologic tool, and can be used to gather real-time information and identification of transmission linkages to assist in infection prevention in immunocompromised patients.


Subject(s)
High-Throughput Nucleotide Sequencing , Immunocompromised Host , Multiple Myeloma/complications , Parainfluenza Virus 3, Human/genetics , Respirovirus Infections/prevention & control , Child , Cross Infection/epidemiology , Cross Infection/prevention & control , Cross Infection/virology , Female , Genome, Viral , Humans , Male , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/virology , Respirovirus Infections/epidemiology , Respirovirus Infections/transmission , Respirovirus Infections/virology , Retrospective Studies
6.
Clin Infect Dis ; 64(11): 1622-1625, 2017 Jun 01.
Article in English | MEDLINE | ID: mdl-28329282

ABSTRACT

A patient with asplenia and multiple red blood cell transfusions acquired babesiosis infection with Babesia divergens-like/MO-1 organisms and not Babesia microti, the common United States species. He had no known tick exposure. This is believed to be the first transfusion-transmitted case and the fifth documented case of B. divergens-like/MO-1 infection.


Subject(s)
Babesiosis/transmission , Blood Transfusion , Aged, 80 and over , Arkansas , Babesia/isolation & purification , Babesiosis/drug therapy , Babesiosis/parasitology , Clindamycin/administration & dosage , Clindamycin/therapeutic use , Doxycycline/administration & dosage , Doxycycline/therapeutic use , Fatal Outcome , Humans , Male , Platelet Transfusion , Quinine/administration & dosage , Quinine/therapeutic use , United States
7.
Transpl Infect Dis ; 19(1)2017 Feb.
Article in English | MEDLINE | ID: mdl-27862750

ABSTRACT

We present the case of a 51-year-old man with acute myeloid leukemia who developed fevers with a skin lesion following the first cycle of induction chemotherapy. Skin biopsy showed evidence of invasive fungal infection. Cultures remained negative, but polymerase chain reaction on tissue detected Rhizopus oryzae complex. The patient was started on liposomal amphotericin B and underwent surgical debridement. He was switched to posaconazole, with plans for allogeneic hematopoetic stem cell transplant in the future.


Subject(s)
Antifungal Agents/therapeutic use , Dermatomycoses/drug therapy , Febrile Neutropenia/drug therapy , Invasive Fungal Infections/therapy , Leukemia, Myeloid, Acute/drug therapy , Mucormycosis/therapy , RNA, Fungal/isolation & purification , Rhizopus/isolation & purification , Amphotericin B/administration & dosage , Amphotericin B/therapeutic use , Antibiotic Prophylaxis/adverse effects , Antifungal Agents/administration & dosage , Biopsy , Debridement , Dermatomycoses/complications , Dermatomycoses/microbiology , Dermatomycoses/pathology , Febrile Neutropenia/etiology , Febrile Neutropenia/microbiology , Forearm , Humans , Immunocompromised Host , Induction Chemotherapy/adverse effects , Induction Chemotherapy/methods , Invasive Fungal Infections/microbiology , Invasive Fungal Infections/pathology , Male , Middle Aged , Mucormycosis/complications , Mucormycosis/microbiology , Mucormycosis/pathology , Polymerase Chain Reaction , Triazoles/administration & dosage , Triazoles/therapeutic use
9.
J Healthc Qual ; 38(6): 359-369, 2016.
Article in English | MEDLINE | ID: mdl-28288090

ABSTRACT

We assessed if use of an online clinical decision support tool improved standardization and quality of care in hospitalized patients with lower extremity cellulitis (LEC). This was a 14-month preintervention and postintervention study of 85 LEC admissions. There was significantly higher usage of the online LEC care process model (CPM) in the postintervention phase (p < .001). There was a trend toward higher rates of appropriate antibiotic regimen in the postintervention group both initially and at discharge (p = .063 for both). A sensitivity analysis of CPM users versus nonusers demonstrated a significantly higher rate of appropriate initial antibiotics prescribed when the CPM was used (p < .001). Use of this online CPM was associated with improved standardization, as demonstrated by increased ordering of an appropriate initial antibiotic regimen for hospitalized patients with LEC.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Cellulitis/drug therapy , Patient Discharge , Decision Support Systems, Clinical , Hospitalization , Humans
10.
HIV AIDS (Auckl) ; 7: 251-64, 2015.
Article in English | MEDLINE | ID: mdl-26604826

ABSTRACT

Patients with human immunodeficiency virus (HIV) are living longer with their disease, as HIV has become a chronic illness managed with combination antiretroviral therapy (cART). This has led to an increasing number of patients greater than 50 years old living successfully with HIV. As the number of older adults with HIV has increased, there are special considerations for the management of HIV. Older adults with HIV must be monitored for drug side effects and toxicities. Their other non-HIV comorbidities should also be considered when choosing a cART regimen. Older adults with HIV have unique issues related to medication compliance. They are more likely than the younger HIV patients to have vision loss, cognitive impairment, and polypharmacy. They may have lower expectations of their overall health status. Depression and financial concerns, especially if they are on a fixed income, may also contribute to noncompliance in the aging HIV population.

11.
Open Forum Infect Dis ; 2(1): ofv011, 2015 Jan.
Article in English | MEDLINE | ID: mdl-26034762

ABSTRACT

Background. Emerging data implicate long-term care facilities (LTCFs) as reservoirs of fluoroquinolone-resistant (FQ-R) Escherichia coli of sequence type 131 (ST131). We screened for ST131 among LTCF residents, characterized isolates molecularly, and identified risk factors for colonization. Methods. We conducted a cross-sectional study using a single perianal swab or stool sample per resident in 2 LTCFs in Olmsted County, Minnesota, from April to July 2013. Confirmed FQ-R E. coli isolates underwent polymerase chain reaction-based phylotyping, detection of ST131 and its H30 and H30-Rx subclones, extended virulence genotyping, and pulsed-field gel electrophoresis (PFGE) analysis. Epidemiological data were collected from medical records. Results. Of 133 fecal samples, 33 (25%) yielded FQ-R E. coli, 32 (97%) of which were ST131. The overall proportion with ST131 intestinal colonization was 32 of 133 (24%), which differed by facility: 17 of 41 (42%) in facility 1 vs 15 of 92 (16%) in facility 2 (P = .002). All ST131 isolates represented the H30 subclone, with virulence gene and PFGE profiles resembling those of previously described ST131 clinical isolates. By PFGE, certain isolates clustered both within and across LTCFs. Multivariable predictors of ST131 colonization included inability to sign consent (odds ratio [OR], 4.16 [P = .005]), decubitus ulcer (OR, 4.87 [ P = .04]), and fecal incontinence (OR, 2.59 [P = .06]). Conclusions. Approximately one fourth of LTCF residents carried FQ-R ST131 E. coli resembling ST131 clinical isolates. Pulsed-field gel electrophoresis suggested intra- and interfacility transmission. The identified risk factors suggest that LTCF residents who require increased nursing care are at greatest risk for ST131 colonization, possibly due to healthcare-associated transmission.

12.
Mayo Clin Proc ; 88(12): 1468-74, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24290121

ABSTRACT

Human immunodeficiency virus (HIV) has evolved from an illness that consistently led to death to a chronic disease that can be medically managed. Primary care clinicians can provide beneficial care to the individual patient and potentially decrease the transmission of HIV to others through appropriate HIV screening and recognition of clinical clues to both chronic and acute HIV. Most patients who take combination antiretroviral therapy experience immune reconstitution and resume normal lives. These patients benefit from the care of an experienced primary care clinician in addition to a clinician with HIV expertise. Primary care clinicians have expertise providing preventive care, including counseling regarding healthier lifestyle choices and managing cardiovascular risk factors, osteoporosis, hypertension, and diabetes, all of which have become increasingly important for individuals with HIV as they age. This article reviews the many important roles of primary care clinicians with regard to the HIV epidemic and care of patients with HIV.


Subject(s)
Anti-HIV Agents/administration & dosage , HIV Infections , Mass Screening , Physician's Role , Primary Health Care , Primary Prevention/methods , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/prevention & control , Acute Disease , Adult , Aged , Bone Density , Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/drug therapy , Cardiovascular Diseases/prevention & control , Chronic Disease , Diagnosis, Differential , Disease Management , Drug Interactions , Female , HIV Infections/complications , HIV Infections/diagnosis , HIV Infections/drug therapy , HIV Infections/prevention & control , Humans , Kidney Diseases/diagnosis , Kidney Diseases/drug therapy , Kidney Diseases/prevention & control , Liver Diseases/diagnosis , Liver Diseases/drug therapy , Liver Diseases/prevention & control , Male , Mass Screening/standards , Middle Aged , Neoplasms/diagnosis , Neoplasms/drug therapy , Neoplasms/prevention & control , Primary Health Care/methods , Primary Health Care/standards , Primary Health Care/trends , Risk Assessment , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...